Severe Acute Respiratory Syndrome CoronaVirus 2
Showing 26 - 50 of >10,000
COVID-19 Trial in New York (Hydroxychloroquine (HCQ))
Completed
- COVID-19
- Hydroxychloroquine (HCQ)
-
New York, New YorkNYU Langone Health
Dec 12, 2022
Vaccination Hesitancy Trial in Oklahoma City, Stillwater (Standard MI, Intensive MI, MOTIVACC)
Not yet recruiting
- Vaccination Hesitancy
- Standard MI
- +3 more
-
Oklahoma City, Oklahoma
- +1 more
Aug 2, 2023
COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Trial in Spain (C19-IG 20%, 0.9% Sodium
Terminated
- COVID-19
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- C19-IG 20%
- 0.9% Sodium chloride
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +11 more
Nov 8, 2022
COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)
Not yet recruiting
- COVID-19 Infection
- COVID-19 Vaccine Adverse Reaction
- LEM-mR203
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital Clinical Trials Center
Sep 12, 2023
Diabetes, Covid19 Trial in Jacksonville (Continuous Glucose Monitor (CGM))
Completed
- Diabetes Mellitus
- Covid19
- Continuous Glucose Monitor (CGM)
-
Jacksonville, FloridaMayo Clinic in Florida
Aug 24, 2022
Thyroid Dysfunction, Hypothyroidism, Hyperthyroidism Trial in Riyadh (Thyroxine)
Completed
- Thyroid Dysfunction
- +2 more
-
Riyadh, Central, Saudi ArabiaSecurity Forces Hospital
May 18, 2022
COVID-19 Biological Samples Collection
Recruiting
- Infection Viral
- biological samples collection
-
Bordeaux, FranceCentre Hospitalier Universitaire de Bordeaux
Dec 7, 2022
Non-invasive Oxygenation Strategies in Patients Admitted for
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Use of High Flow Nasal Cannula alone
- +2 more
-
Béthune, Nord-Pas-de-Calais, France
- +3 more
Oct 10, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trial (Favipiravir HU 200 mg hard capsules, Placebo HU)
Terminated
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Favipiravir HU 200 mg hard capsules
- Placebo HU
-
Szeged, HungaryUniversity of Szeged - Internal Medicine
Nov 4, 2022
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder) Trial in Los Angeles (MBS-COV, Placebo)
Recruiting
- Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
- MBS-COV
- Placebo
-
Los Angeles, CaliforniaPhase I Unit
Jan 10, 2023
Severe Acute Respiratory Syndrome Coronavirus 2, Aspergillosis Invasive Trial in Orange, Sacramento, San Diego (Isavuconazonium
Terminated
- Severe Acute Respiratory Syndrome Coronavirus 2
- Aspergillosis Invasive
- Isavuconazonium Injection [Cresemba]
- Placebo
-
Orange, California
- +2 more
Jul 26, 2022
Coronavirus Disease 2019, Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Trial in United States (Varespladib,
Terminated
- Coronavirus Disease 2019
- Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
- Varespladib
- Placebo
-
Ventura, California
- +6 more
Dec 14, 2022
The Clinical Manifestations of Severe Acute Respiratory
Completed
- Covid19
-
Assiut, EgyptAssiut University Hospital
Jun 5, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Halifax, Saskatoon (COVAC-2, Saline Placebo)
Active, not recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVAC-2
- Saline Placebo
-
Halifax, Nova Scotia, Canada
- +1 more
Aug 5, 2022
Severe Acute Respiratory Syndrome Coronavirus 2, Severe Acute Respiratory Distress Syndrome Trial in Paris (Umbilical cord
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- Severe Acute Respiratory Distress Syndrome
- Umbilical cord Wharton's jelly-derived human
- NaCl 0.9%
-
Paris, France
- +1 more
Feb 17, 2022
COVID-19 Trial in Napoli, Roma (Hydrogen peroxide, Placebo)
Withdrawn
- COVID-19
- Hydrogen peroxide
- Placebo
-
Roma, ItalyClinica Nuova ITOR
Nov 20, 2022
Assess Infection Rate of Severe Acute Respiratory Syndrome -
Completed
- Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)
-
Chicago, IllinoisGreat Lakes Clinical Trials /ID# 224874
Oct 6, 2022
Cardiometabolic Syndrome, Weight Loss Trial in Winnipeg (Lifestyle program)
Active, not recruiting
- Cardiometabolic Syndrome
- Weight Loss
- Lifestyle program
-
Winnipeg, Manitoba, CanadaChronic Disease Innovation Centre, Seven Oaks Hospital
Apr 21, 2022
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and
Active, not recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- +2 more
- SARS-CoV-2 and/or MIS-C Exposure
-
Loma Linda, California
- +19 more
Sep 22, 2022
COVID 19 Disease, Mild to Moderate COVID 19 Disease, SARS-CoV-2 Trial (Tafenoquine Oral Tablet, Placebo)
Not yet recruiting
- COVID 19 Disease
- +4 more
- Tafenoquine Oral Tablet
- Placebo
- (no location specified)
Jul 13, 2023
Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Bobo-Dioulasso, Conakry (Nitazoxanide
Recruiting
- Covid19
- +3 more
- Nitazoxanide and Ciclésonide
- +3 more
-
Bobo-Dioulasso, Burkina Faso
- +1 more
Jan 30, 2023
SARS-CoV-2, COVID-19 Trial in Monaco (ELISA POCT vs RT-PCR)
Recruiting
- SARS-CoV-2
- COVID-19
- ELISA POCT vs RT-PCR
-
Monaco, MonacoCentre National de Depistage - Espace Leo Ferre
Oct 19, 2021
Corona Virus Disease 19 (Covid19), Corona Virus Infection, Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2) Trial in
Completed
- Corona Virus Disease 19 (Covid19)
- +2 more
-
Cairo, EgyptAl Assema Hospital
Apr 25, 2022
Index Individuals in SARS-CoV-2 Prevention Research Studies
Completed
- SARS-CoV-2 Infection
- +3 more
-
Seattle, WashingtonUniversity of Washington International Clinical Research Center
Dec 6, 2021
EuGeni Rapid Antigen Test for Qualitative Detection of Severe
Terminated
- SARS-CoV-2 Infection
- EuGeni SARS-CoV-2 Antigen Rapid Diagnostic Test
-
Split, Croatia
- +4 more
Jan 3, 2023